about
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancerClinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clonesDetection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditionsPredictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting.Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: a review.Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method.Rapid detection of low-abundance K-ras mutation in stools of colorectal cancer patients using chip-based temperature gradient capillary electrophoresis.Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.Reply: KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?
P2860
Q21142734-2EFAC793-F376-4941-BDFF-9DC11B22482AQ27851527-039274E8-933E-49EB-AF0A-707456BFA912Q34565052-0F99491D-A527-4E15-83EF-1843756532D4Q35986751-5E0A4696-3FFA-4D13-BE32-F01E25BA662FQ37015715-475CC6AB-AA05-4D15-947D-70098AEB676CQ37396252-C16CAFEA-CF7C-494C-A768-FE3DFA824CD7Q37916396-533F893D-0F6B-4B18-BFAA-CD7693AA022CQ39416581-205DA75F-4756-4254-91E4-E8EE95FE16C2Q39606707-BF4BAA91-2B67-4567-A40A-54A620CFAFF8Q54415409-D0DCA77B-5ED8-4720-81EC-D1EFA228AC4AQ55689709-4510DDDC-32AC-4336-B657-7D8F77120390
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
K-ras mutations and cetuximab in colorectal cancer.
@en
type
label
K-ras mutations and cetuximab in colorectal cancer.
@en
prefLabel
K-ras mutations and cetuximab in colorectal cancer.
@en
P356
P1476
K-ras mutations and cetuximab in colorectal cancer.
@en
P2093
Antonio Marchetti
Giampietro Gasparini
P304
833-4; author reply 835-6
P356
10.1056/NEJMC082346
P407
P577
2009-02-01T00:00:00Z